COVID-19 Pandemic Alters Influenza Vaccine Uptake Dynamics in Kyrgyzstan
A study published in the journal Vaccine reveals that the COVID-19 pandemic has significantly impacted influenza vaccine uptake dynamics in high-risk groups in Kyrgyzstan. The research, conducted by the Task Force for Global Health, analyzed data from 7,200 individuals and found that the pandemic has altered socio-demographic predictors and knowledge, attitudes, and practices (KAP) patterns regarding influenza vaccination. The study highlights the need for adaptable, context-sensitive vaccination strategies and robust public health interventions to sustain immunization progress in evolving epidemiological landscapes.
Key Takeaways:
- The COVID-19 pandemic has reshaped influenza vaccine uptake dynamics in high-risk groups in Kyrgyzstan, altering socio-demographic predictors and KAP patterns.
- Pregnant women with lower education and employment were more likely to intend to vaccinate against influenza before the pandemic, but this association weakened during the pandemic.
- Adults with chronic diseases who were divorced or distrusted the vaccine's protective effect were more likely to intend to vaccinate during the pandemic.
- Healthcare workers with 5 years of experience and those treating children were more likely to recommend vaccines during the pandemic.
- Prioritization of target groups shifted during the pandemic: older adults and comorbid patients gained emphasis, while children and medical staff were prioritized earlier.
Statistics:
- 11% to 50% influenza vaccine uptake among risk groups in Kyrgyzstan despite a national immunization program.
- 2.2 (95% CI 1.4-3.2) lower education increased vaccination intent among pregnant women before the pandemic.
- 1.4 (95% CI 1.0-1.8) employment increased vaccination intent among pregnant women before the pandemic.
- 2.74 (95% CI 1.12-6.6) divorced individuals with chronic diseases remained more likely to intend to vaccinate during the pandemic.
- 2.39 (95% CI 1.24-4.6) healthcare workers with 5 years of experience were more likely to recommend vaccines during the pandemic.
Sources:
- Vaccine, 2025;56:127159. By Rakhat Akmatova, Dinara Otorbaeva, and Malembe S. Ebama.
- Task Force for Global Health.
- Elsevier Sci Ltd, 125 London Wall, London, England.
- NewsRx.
- Pediatrics Week. May 24, 2025; p 5.